CVOR Surgical Tech PRN - Float Pool
About the job
- One year of open-heart surgical technology experience is required.
- Graduation from a vocational surgical technology school or three years of surgical technology experience is required.
- Basic Cardiac Life Support (BCLS) certification is required.
- Scrub and provide instruments, sutures, and other sterile supplies during open-heart and vascular surgical procedures; anticipate equipment and supply needs based on patient, physician, and procedure requirements; prepare cases efficiently; and follow perioperative departmental operating policies.
- Prepare for surgical procedures by selecting appropriate instruments and supplies and ensuring instruments are in working order.
- Apply aseptic technique and universal precautions before, during, and after operative procedures.
- Maintain accountability for instrumentation and return it to the decontamination room or Central Sterile Processing Department in an organized manner, following instrument maintenance principles and decontamination procedures and standards.
- Participate as a member of the healthcare team, including orienting and instructing personnel functioning in the scrub role.
- Restock and clean operating rooms and equipment, maintain a clean, safe, and orderly work environment, and report unsafe conditions.
- Participate in planning, orienting, teaching, and guiding staff and students, and evaluating their function and performance.
- Use material resources cost-effectively and recommend cost-saving measures within the department or assigned area.
- Contribute to staff recruitment and retention through positive role modeling, fostering peer relationships, and participating in preceptor or mentor programs.
- Maintain current knowledge of standards, patient care technology, and agency regulations as part of personal development.
- Participate in in-services, mandatory meetings, and process improvement activities; ensure practice and performance reflect knowledge of relevant compliance, regulations, legislation, certification, and organizational and departmental policies.
- Six months of first-scrub experience is preferred.
- Tech in Surgery – Certified (TS-C) certification is preferred.
About the company
Preparing company summary for Honor Health.
Company Size
5,001-10,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Scottsdale, Arizona
Founded
2013
Get referred to Honor Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- In January 2026, HonorHealth finalized 11 Evernorth Care Group locations from Cigna.
- Deer Valley expanded from 204 to 238 beds after a $170 million rebuild.
- HonorHealth won AACN Bronze Beacon and now holds 12 Beacon units, Arizona's most.
What critics are saying
- Fitch downgraded HonorHealth to A in March 2026; weak margins choke capital access.
- The EEOC sued HonorHealth on September 28, 2026 over disability accommodations and forced departures.
- HonorHealth v. Abboud keeps medical-lien litigation alive after Arizona's Supreme Court denial on September 9.
What makes Honor Health unique
- HonorHealth spans nine hospitals and 270-plus access points across greater Phoenix.
- HonorHealth Research Institute runs 200-plus studies with TGen and major university partnerships.
- HonorHealth became ASU's primary clinical affiliate and launched Arizona's first breast oncology fellowship.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Hybrid Work Options
Company News
Dr. Sunil Sharma, a top physician-scientist at HonorHealth Research Institute, is named 'Arizona Bioscience Researcher of the Year' * Share * Post * Share Dr. Sharma, who heads the Research Institute's Center for Translational Science, is honored by the Arizona Bioindustry Association SCOTTSDALE, Ariz. - Sept. 23, 2026 - Sunil Sharma, M.D., FACP, M.B.A., director of the Center for Translational Science at HonorHealth Research Institute, has been named by the Arizona Bioindustry Association (AZBio) as the Arizona Bioscience Researcher of the Year. Dr. Sharma will be honored at the 2026 AZBio Awards, on Oct. 7 at the Phoenix Convention Center. The 23rd annual awards banquet is part of Arizona Bioscience Week, Oct. 5-9. "Recognized for his outstanding contributions to biological research and drug discovery, Dr. Sharma exemplifies what it means to push the frontiers of modern medicine," according to Joan Koerber-Walker, President and CEO of AZBio. "As Chief of Translational Research and Drug Discovery and Director of the Center for Translational Science at the HonorHealth Research Institute - as well as an ASU Research Professor at the John Shufeldt School of Medicine and Medical Engineering - Dr. Sharma has built a career around translating bench science into real-world patient outcomes." "Dr. Sharma has directly shaped global healthcare by contributing to the development of landmark therapies during his tenure in pharmaceutical leadership," said Koerber-Walker. "His work supported the development of breakthrough immunotherapies - including pembrolizumab (Keytruda) and nivolumab (Opdivo) - which train the human immune system to target and eliminate cancer cells, as well as targeted therapies like ceritinib for lung cancer." The Institute's leadership agrees, praising Dr. Sharma for his emphasis on treating patients: * Mark Slater, Ph.D., the Institute's CEO and Vice President of Research for the HonorHealth network: "We here at the HonorHealth Research Institute are so proud to have Dr. Sharma as our head of the Center for Translational Research. What really distinguishes him is his ability as an innovator to not only develop new understandings of disease, but to develop new tools and therapies from that understanding that makes a real difference for patients." * Michael Gordon, M.D., F.A.S.C.O., the Institute's Chief Medical Officer: "He has spent his career focusing on... patient care. When you hear him speaking about treating a patient, he comes to it with a depth of experience that really drives you to appreciate and understand that his goal is patient care." * Chad Adams, M.P.H., the Institute's Chief Operating Officer: "I think Dr. Sharma particularly brings to the table a very strong scientific mind. He also has collaborators from all over the world. He really wants to find solutions. He's willing to collaborate to find solutions to the gaps that exist in healthcare." Dr. Sharma, who describes himself as a physician-scientist, said he has always been interested how basic scientific research can lead to innovation, and how new treatments and new technologies, especially now, can benefit cancer patients. Of his award, Dr. Sharma said, "I think mostly it's recognition for the kind of work that we're doing and it's hopefully a great recognition for translational science in general, that it's important and that it can add something to the (Arizona) bioscience corridor that we're all trying to build." According to Koerber-Walker: "By uniting academic research, industry collaboration, and clinical execution, Dr. Sunil Sharma is not only advancing our fundamental understanding of biological processes - he is actively changing what is possible for patients in Arizona and around the world." For more about HonorHealth Research Institute clinical trials: call 833-354-6667; or email [email protected]. About the HonorHealth Research Institute HonorHealth Research Institute is an international destination that is at the forefront of providing patients with a better quality of life through its clinical trials and innovative treatment options. Headquartered in Scottsdale, Arizona, the institute's team of physicians and researchers collaborate with experts from across the nation to offer life-changing therapies, drugs and devices. At HonorHealth Research Institute, patients have access to tomorrow's health innovations, today. Learn more at: www.honorhealthresearch.org. For information about the AZBio Awards, visit AZBioAwards.com Share and enjoy!
MBTN announces Dr. Joh Evans Coleman as featured speaker at the 2026 Neuro-Oncology Symposium. The Meningioma Brain Tumor Network, Inc. (MBTN) is proud to announce that Dr. Joh Evans Coleman, Founder and CEO of MBTN, will serve as a featured speaker at the upcoming Neuro-Oncology Symposium hosted by the University of Arizona College of Medicine - Phoenix, HonorHealth, and Banner Health on October 17, 2026. This year's symposium brings together leading clinicians, researchers, and patient-advocacy organizations to explore the latest innovations in brain and spine tumor diagnostics, treatments, and multidisciplinary care. Within this forward-looking scientific program, Dr. Evans Coleman will deliver a powerful session titled: "Living with a Brain Tumor - Patient and Family Perspectives" As a meningioma brain tumor survivor-thriver, nonprofit founder, and national advocate for patient-centered neuro-oncology, Dr. Evans Coleman brings a uniquely human lens to a field often dominated by clinical and research discourse. Her session will highlight: * The lived realities of navigating a brain tumor diagnosis * The emotional, cognitive, and physical challenges faced by survivors * The critical role of family and care partner support systems * Gaps in care that patients-survivors-thrivers experience across the treatment continuum * Survivor-Thriver centered strategies for improving quality of life * The importance of advocacy, community, and equitable access to care Dr. Evans Coleman's work through MBTN has helped elevate survivor voices, expand public awareness, and strengthen community-based support for individuals and families impacted by meningioma and other brain tumors. Her participation in this symposium underscores the growing recognition that patient experience is essential to advancing neuro-oncology practice. A Symposium Bridging Science, Innovation, and Humanity The Neuro-Oncology Symposium will convene at the Health Sciences Education Building in Phoenix, bringing together experts across neurosurgery, neuro-oncology, radiation oncology, imaging, and survivorship care. While the event will spotlight cutting-edge advancements in tumor diagnostics and treatment innovation, it also emphasizes the importance of multidisciplinary collaboration - including the voices of survivors and caregivers. Dr. Evans Coleman's session ensures that the lived experience remains central to the conversation. MBTN's Commitment to Advocacy and Education MBTN continues to expand its national footprint as a leader in survivor-thriver-centered education, advocacy, and community support. Events like the Neuro-Oncology Symposium strengthen MBTN's mission to ensure every patient/survuvor-thriver, care partner, and family has access to knowledge, empowerment, and compassionate care. MBTN celebrates Dr. Evans Coleman's ongoing leadership and invites supporters, clinicians, researchers, and community members to join this important event.
HonorHealth announces CEO transition; John Neil to succeed Todd LaPorte in March 2027. Jun 16, 2026 HonorHealth announced on June 16 that Chief Executive Officer Todd LaPorte will step down from his role in March 2027, after more than a decade of leadership. The HonorHealth Board of Directors has named John Neil, MD, MMM, currently Executive Vice President, Chief Physician Executive and Chief Strategy Officer, as his successor. As part of the planned transition, Dr. Neil will assume the role of President immediately and become CEO on March 1, 2027. LaPorte will remain CEO until that date, and then serve as a strategic advisor to the new CEO. LaPorte's tenure included expanding HonorHealth's network to over 270 access points across the region and supporting recovery efforts for distressed hospitals in the Valley. He also focused on enhancing clinical outcomes for patients, strengthening financial performance and sustainability, elevating HonorHealth Research Institute's national profile, navigating through a global pandemic, and deepening community health initiatives. "HonorHealth is in an exceptionally strong position today," said LaPorte. "We have built tremendous momentum, and I am confident about the organization's future. It has been an honor to serve alongside such a dedicated team, and I look forward to supporting the next chapter of leadership." In his upcoming advisory role, LaPorte will continue working on community impact projects and healthcare advocacy initiatives for both HonorHealth and broader healthcare efforts. Dr. Neil brings experience in clinical care and executive leadership within HonorHealth's network. Mike Welborn, Chair of the Board at HonorHealth, said: "John is a highly respected leader who understands our mission, our people and our communities...his leadership will ensure continuity while driving continued innovation and growth." Dr. Neil said: "I am honored to step into this role and build on the strong foundation Todd and our teams have created...I look forward to working with our team to continue advancing our mission of improving the health and well-being of those we serve." The transition underscores HonorHealth's commitment to long-term planning for organizational success. The Scottsdale Area Chamber of Commerce supports community growth by promoting economic development through education programs; it collaborates with local partners including Arizona State University; it advocates for business-friendly policies via its Public Policy Advisory Committee; its services extend throughout Scottsdale, according to the official website.
HonorHealth announces CEO transition plan; EVP John Neil, MD, MMM, named successor to Todd LaPorte. HonorHealth announced a planned CEO transition, naming John Neil, MD, MMM, as successor to Todd LaPorte, effective March 1, 2027. I am honored to build on the strong foundation Todd and our teams have created. Together, we'll continue advancing our mission of improving the health and well-being of those we serve." - John Neil, M.D. SCOTTSDALE, AZ, UNITED STATES, June 16, 2026 / EINPresswire.com / - HonorHealth today announced that Chief Executive Officer Todd LaPorte will transition from his role in March 2027 following more than a decade of transformative leadership. The HonorHealth Board of Directors has named John Neil, MD, MMM, current Executive Vice President, Chief Physician Executive and Chief Strategy Officer, as his successor. As part of a planned leadership transition, Dr. Neil will assume the role of President immediately, prior to becoming CEO on March 1, 2027. LaPorte will remain CEO until that date, after which he will serve as a strategic advisor to the CEO. LaPorte's tenure has been defined by strong growth, innovation and a deep commitment to advancing healthcare in the communities HonorHealth serves. Under his leadership, HonorHealth has: - Expanded its network of care locations and services across the region - now with more than 270 access points - Supported recovery and stabilized operations for distressed hospitals in the Valley - Enhanced clinical excellence and quality outcomes for patients - Strengthened its financial performance and long-term sustainability - Elevated the national profile of HonorHealth Research Institute - Navigated through a global pandemic - Deepened a commitment to community health initiatives, outreach and partnerships "HonorHealth is in an exceptionally strong position today," said LaPorte. "We have built tremendous momentum, and I am confident about the organization's future. It has been an honor to serve alongside such a dedicated team, and I look forward to supporting the next chapter of leadership." In his new role as strategic advisor to the CEO, LaPorte will continue focusing on community impact, healthcare advocacy and key initiatives that benefit the organization and the broader healthcare landscape. Dr. Neil brings extensive clinical and executive leadership experience and has played a key role in advancing physician integration, care delivery, strategic growth and a people-first culture across the network. "John is a highly respected leader who understands our mission, our people and our communities," said Mike Welborn, HonorHealth Board Chair. "He has served the medical mission of this community in some capacity for the past 27 years, and his leadership will ensure continuity while driving continued innovation and growth." "I am honored to step into this role and build on the strong foundation Todd and our teams have created," said Dr. Neil. "HonorHealth is well positioned for the future, and I look forward to working with our team to continue advancing our mission of improving the health and well-being of those we serve." The transition reflects HonorHealth's commitment to long-term strategic planning and leadership continuity, ensuring the organization remains well positioned for continued success. About HonorHealth HonorHealth is one of Arizona's largest nonprofit healthcare systems, serving a population of five million people in the greater Phoenix metropolitan area. The comprehensive network encompasses nine acute-care hospitals, an extensive medical group with primary, specialty and urgent care services, a cancer care network, outpatient surgery centers, clinical research, medical education, a foundation, an accountable care organization, community services and more. With more than 17,000 team members, 4,000+ affiliated providers and over 1,300 volunteers, HonorHealth seamlessly blends collaborative care and approachable expertise to improve health and well-being. People often say care feels different here - because it does. Learn more at HonorHealth.com. All of us. All for you TV commercial Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
HonorHealth announces CEO transition plan; EVP John Neil, MD, MMM, named successor to Todd LaPorte. HonorHealth announced a planned CEO transition, naming John Neil, MD, MMM, as successor to Todd LaPorte, effective March 1, 2027. I am honored to build on the strong foundation Todd and its teams have created. Together, The MarCom Journal'll continue advancing its mission of improving the health and well-being of those The MarCom Journal serve." - John Neil, M.D. SCOTTSDALE, AZ, UNITED STATES, June 16, 2026 / EINPresswire.com / - HonorHealth today announced that Chief Executive Officer Todd LaPorte will transition from his role in March 2027 following more than a decade of transformative leadership. The HonorHealth Board of Directors has named John Neil, MD, MMM, current Executive Vice President, Chief Physician Executive and Chief Strategy Officer, as his successor. As part of a planned leadership transition, Dr. Neil will assume the role of President immediately, prior to becoming CEO on March 1, 2027. LaPorte will remain CEO until that date, after which he will serve as a strategic advisor to the CEO. LaPorte's tenure has been defined by strong growth, innovation and a deep commitment to advancing healthcare in the communities HonorHealth serves. Under his leadership, HonorHealth has: - Expanded its network of care locations and services across the region - now with more than 270 access points - Supported recovery and stabilized operations for distressed hospitals in the Valley - Enhanced clinical excellence and quality outcomes for patients - Strengthened its financial performance and long-term sustainability - Elevated the national profile of HonorHealth Research Institute - Navigated through a global pandemic - Deepened a commitment to community health initiatives, outreach and partnerships "HonorHealth is in an exceptionally strong position today," said LaPorte. "We have built tremendous momentum, and I am confident about the organization's future. It has been an honor to serve alongside such a dedicated team, and I look forward to supporting the next chapter of leadership." In his new role as strategic advisor to the CEO, LaPorte will continue focusing on community impact, healthcare advocacy and key initiatives that benefit the organization and the broader healthcare landscape. Dr. Neil brings extensive clinical and executive leadership experience and has played a key role in advancing physician integration, care delivery, strategic growth and a people-first culture across the network. "John is a highly respected leader who understands our mission, our people and our communities," said Mike Welborn, HonorHealth Board Chair. "He has served the medical mission of this community in some capacity for the past 27 years, and his leadership will ensure continuity while driving continued innovation and growth." "I am honored to step into this role and build on the strong foundation Todd and our teams have created," said Dr. Neil. "HonorHealth is well positioned for the future, and I look forward to working with our team to continue advancing our mission of improving the health and well-being of those we serve." The transition reflects HonorHealth's commitment to long-term strategic planning and leadership continuity, ensuring the organization remains well positioned for continued success. About HonorHealth HonorHealth is one of Arizona's largest nonprofit healthcare systems, serving a population of five million people in the greater Phoenix metropolitan area. The comprehensive network encompasses nine acute-care hospitals, an extensive medical group with primary, specialty and urgent care services, a cancer care network, outpatient surgery centers, clinical research, medical education, a foundation, an accountable care organization, community services and more. With more than 17,000 team members, 4,000+ affiliated providers and over 1,300 volunteers, HonorHealth seamlessly blends collaborative care and approachable expertise to improve health and well-being. People often say care feels different here - because it does. Learn more at HonorHealth.com. All of The MarCom Journal. All for you TV commercial Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. The MarCom Journal do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.